Optical coherence tomography in coronary atherosclerosis assessment and intervention

M Araki, SJ Park, HL Dauerman, S Uemura… - Nature Reviews …, 2022 - nature.com
Since optical coherence tomography (OCT) was first performed in humans two decades ago,
this imaging modality has been widely adopted in research on coronary atherosclerosis and …

Coronary In-Stent Restenosis: JACC State-of-the-Art Review

G Giustino, A Colombo, A Camaj, K Yasumura… - Journal of the American …, 2022 - jacc.org
The introduction and subsequent iterations of drug-eluting stent technologies have
substantially improved the efficacy and safety of percutaneous coronary interventions …

Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial

B Cortese, G Di Palma, MG Guimaraes… - Cardiovascular …, 2020 - jacc.org
Objectives This study sought to compare the performance of a novel drug-coated balloon
(DCB)(Elutax SV, Aachen Resonance, Germany), with an everolimus-eluting stent …

[PDF][PDF] SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease

RF Riley, TD Henry, E Mahmud… - Catheter …, 2020 - studioyszimg.yxj.org.cn
I. Introduction The anatomic and clinical complexity of patients with coronary artery disease
(CAD) is increasing in the United States. 1–3 While the terms “complex CAD” or “high-risk …

2-year outcomes of angiographic quantitative flow ratio-guided coronary interventions

L Song, B Xu, S Tu, C Guan, Z Jin, B Yu, G Fu… - Journal of the American …, 2022 - jacc.org
Background In the multicenter, randomized, sham-controlled FAVOR (Comparison of
Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in …

Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial

R Ferrari, I Ford, K Fox, JP Challeton, A Correges… - The Lancet, 2020 - thelancet.com
Background Angina might persist or reoccur despite successful revascularisation with
percutaneous coronary intervention (PCI) and antianginal therapy. Additionally, PCI in …

[HTML][HTML] Stent thrombosis and restenosis with contemporary drug-eluting stents: predictors and current evidence

F Condello, C Spaccarotella, S Sorrentino… - Journal of Clinical …, 2023 - mdpi.com
Iterations in stent technologies, advances in pharmacotherapy, and awareness of the
implications of implantation techniques have markedly reduced the risk of stent failure, both …

Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials

MV Madhavan, JP Howard, A Naqvi… - European Heart …, 2021 - academic.oup.com
Aims Contemporary 2nd-generation thin-strut drug-eluting stents (DES) are considered
standard of care for revascularization of patients undergoing percutaneous coronary …

Contemporary coronary drug-eluting and coated stents: a mini-review

Y Saito, Y Kobayashi - Cardiovascular intervention and therapeutics, 2021 - Springer
Percutaneous coronary intervention has become a standard-of-care procedure in patients
with acute and chronic coronary syndromes, in which coronary stent technology is …

[HTML][HTML] Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries: Long-term outcomes of ISR PCI

H Tamez, EA Secemsky, L Valsdottir, I Moussa… - …, 2021 - ncbi.nlm.nih.gov
Background In-stent restenosis (ISR) is highly prevalent and leads to repeat
revascularisation. Long-term implications of ISR are poorly understood. Aims This study …